Notice: Internet Explorer 11 users may encounter issues loading pages throughout the website. Please turn on IE-11’s compatibility mode while we work to resolve the issue.

>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

FDA Reports the Propofol Shortage is Resolved

Tuesday, June 11, 2013

The Food and Drug Administration (FDA) has officially moved propofol injections from the list of drugs currently in shortage to the list of resolved drug shortages.  While the FDA has indicated that propofol is currently available, it may take time for facilities to secure product as it moves through the supply chain.  

If you are not able to access adequate quantities of propofol, please contact the FDA at drugshortages@fda.hhs.gov and Lisa Pearlstein, ASA Pain Medicine and Regulatory Lobbyist, at l.pearlstein@asawash.org

Learn more about ASA's leadership in combating drug shortages.

« Back to Washington Alerts